Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease

Summary

To provide open-label re-treatment with PROCHYMAL to participants enrolled in companion Protocol 603 to evaluate the safety in participants with active Crohn's disease who are resistant to standard Crohn's disease therapies.

Timeline

Start

2010-11-29

Primary completion

2014-09-15

Completion

2014-09-15

Drugs

Indications